Cases 51 - 60 of 122
Boehringer Ingelheim International GmbH et al v. Lupin Ltd. et al
as 1:2019cv01866
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. et al
as 1:2019cv01497
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eisai Co., Ltd. et al v. Lupin Limited et al
as 1:2019cv01336
Plaintiff:
Novartis Pharma AG, Eisai Inc. and Eisai Co., Ltd.
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Limited
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals International GmbH et al v. Lupin, Ltd. et al
as 1:2019cv01251
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin, Ltd.
Plaintiff:
Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. and Cephalon, Inc.
Cause Of Action: 35 U.S.C. § 271
Ferring Pharmaceuticals Inc. et al v. Lupin Inc. et al
as 1:2019cv00913
Defendant:
Lupin Ltd., Lupin Inc., Lupin Pharmaceuticals, Inc. and others
Plaintiff:
Ferring B.V., Ferring Pharmaceuticals Inc. and Ferring International Center S.A.
Cause Of Action: 35 U.S.C. § 183
Bausch Health Ireland Limited et al v. Lupin Ltd. et al
as 1:2019cv00626
Plaintiff:
Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. and Norgine B.V.
Defendant:
Lupin Ltd., Lupin Inc., Lupin Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Lupin Limited et al
as 1:2019cv00347
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. v. Lupin Ltd. et al.
as 1:2019cv00110
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
